ANSBERT GADICKE - Director at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CGEM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ANSBERT GADICKE since 05 Jan 2025

Holdings reported by ANSBERT GADICKE for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,648,268 $95,297,419 $12.46 31 Dec 2021 Indirect
Common Stock 595,489 $7,419,793 $12.46 21 Dec 2021 Direct
Stock Option (Right to Buy) 16,475 22 Jun 2022 Direct Common Stock

Transactions reported by ANSBERT GADICKE for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.